Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net margin is calculated as Net Income divided by its Revenue. ETHK Labs's Net Income for the
six
months ended in Dec. 2025 was HK$-5 Mil. ETHK Labs's Revenue for the
six
months ended in Dec. 2025 was HK$1,714 Mil. Therefore, ETHK Labs's net margin for the quarter that ended in Dec. 2025 was -0.27%.
The historical rank and industry rank for ETHK Labs's Net Margin % or its related term are showing as below:
HKSE:01931'
s Net Margin % Range Over the Past 10 Years
Min: 1.23 Med: 7.97 Max: 32.74
Current: 1.23
HKSE:01931's Net Margin % is ranked worse than 55.93% of 118
companies
in the Medical Distribution industry
Industry Median: 1.425
vs HKSE:01931: 1.23
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
ETHK Labs Net Margin % Related Terms
ETHK Labs Net Margin % Historical Data
* Premium members only.
The historical data trend for ETHK Labs's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01931 vs MCK, COR, CAH: Net Margin % Comparison
For the Medical Distribution subindustry, ETHK Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's Net Margin % distribution charts can be found below:
* The bar in red indicates where ETHK Labs's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETHK Labs (HKSE:01931) has a Net Margin % of -0.27% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on ETHK Labs and its competitors. Over the past decade, ETHK Labs' Net Margin % has ranged from 1.23 to 32.74. According to the industry distribution chart, ETHK Labs ranks #66 out of 118 companies in the Medical Distribution industry, placing it in the top 55.9%.
Is ETHK Labs' Net Margin % too high?
ETHK Labs' current Net Margin % is -0.27%. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 32.74. Based on the distribution chart, ETHK Labs ranks #66 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ETHK Labs ranks #66 out of 118 companies for Net Margin %. This places ETHK Labs in the lower half of its industry. The industry median Net Margin % is 1.43. Historically, ETHK Labs' own Net Margin % has ranged from 1.23 to 32.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.43, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on ETHK Labs and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current Net Margin % is -0.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.58 — trading 58% below its estimated fair value. The current Net Margin % is -0.27%. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current Net Margin % is -0.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.58 is trading 58% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
Net Margin %: -0.27%
GF Value™: HK$1.38 vs. price of HK$0.58 (58% below fair value)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
